Which clotting factors are assessed by the Prothrombin Time screening test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prothrombin Time Screening Test

The correct answer is E (A and C): The Prothrombin Time screens for Factor X, Factor V, Factor II (prothrombin), Fibrinogen (option A) AND Factor VII (option C). 1, 2, 3

Factors Assessed by PT

The PT evaluates the extrinsic and common pathways of the coagulation cascade, specifically measuring the activity of:

  • Factor VII (extrinsic pathway - half-life 6 hours) 1
  • Factor X (common pathway) 1, 3
  • Factor V (common pathway) 1, 3
  • Factor II/Prothrombin (common pathway - half-life 60-72 hours) 1, 3
  • Factor I/Fibrinogen (common pathway) 1, 3

Why Option E is Correct

The PT responds to reduction of 3 of the 4 vitamin K-dependent procoagulant clotting factors (II, VII, and X) that are reduced by warfarin at rates proportionate to their respective half-lives. 1 During the first few days of warfarin therapy, the PT reflects mainly reduction of Factor VII due to its short 6-hour half-life, with subsequent contributions from Factors X and II. 1

Factor V and Fibrinogen, while not vitamin K-dependent, are also assessed by the PT as they participate in the common pathway. 3, 4

Why Other Options are Incorrect

Option B factors (FXII, FXI, FIX, FVIII) are NOT assessed by PT - these belong to the intrinsic pathway and are evaluated by the activated partial thromboplastin time (aPTT), not PT. 1, 3 The aPTT evaluates the intrinsic and common pathways, measuring factors XII, XI, IX, VIII, X, V, II, and I. 3

Clinical Mechanism

The PT assay is performed by adding calcium and thromboplastin (tissue factor) to citrated plasma. 1 The thromboplastin contains both tissue factor and phospholipid necessary to promote activation of Factor X by Factor VII, initiating the extrinsic pathway. 1 This bypasses the intrinsic pathway factors entirely, which is why FXII, FXI, FIX, and FVIII do not affect PT results. 3

Diagnostic Algorithm

When PT is prolonged:

  • Measure Factors II, V, VII, and X to identify the specific deficiency 2
  • Perform 50:50 mixing study to differentiate factor deficiency from inhibitor 2
  • If mixing study corrects, proceed with specific factor assays 2
  • Isolated Factor VII deficiency causes isolated PT prolongation without aPTT abnormality 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Blood Work to Diagnose Clotting Factor Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Coagulation Cascade and Its Relationship with Coagulation Times

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prolonged Prothrombin Time Causes and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.